Invertebrate models of Kallmann Syndrome: Molecular pathogenesis and new disease genes

Current Genomics

Volumn 14, Issue 1, 2013, Pages 2-10

  Di Schiavi, Elia ^a   Andrenacci, Davide ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

Animal models; Axon branching; CeKal 1; DmKal 1; Extracellular matrix; Morphogenesis

Indexed keywords

ANOSMIN 1; CHROMODOMAIN HELICASE DNA BINDING PROTEIN 7; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBRONECTIN; FIBRONECTIN III; GROWTH FACTOR RECEPTOR; PROKINETICIN 2; PROKINETICIN 2 RECEPTOR; PROTEINS AND PEPTIDES; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; WHEY ACIDIC PROTEIN;

CAENORHABDITIS ELEGANS; DISEASE MODEL; DROSOPHILA MELANOGASTER; GENE; GENE INTERACTION; GENE MUTATION; GENE OVEREXPRESSION; HS6ST1 GENE; HUMAN; KAL1 GENE; KALLMANN SYNDROME; MOLECULAR PATHOLOGY; MORPHOGENESIS; NERVE FIBER GROWTH; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALIA; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; INVERTEBRATA; MURINAE; MUS;

EID: 84888218718     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/138920213804999174     Document Type: Review

References (69)

1. Kallmann, F.; Schoenfeld, W.; Barrera, S., The genetic aspects of primary eunuchoidism. Am J Ment Defic 1944, 48, 203-236.
2. Turner, R. C.; Bobrow, L. G.; MacKinnon, P. C.; Bonnar, J.; Hockaday, T. D.; Ellis, J. D., Cryptorchidism in a family with Kallmann's syndrome. Proc R Soc Med 1974, 67 (1), 33-35.
3. Wegenke, J. D.; Uehling, D. T.; Wear, J. B., Jr.; Gordon, E. S.; Bargman, J. G.; Deacon, J. S.; Herrmann, J. P.; Opitz, J. M., Familial Kallmann syndrome with unilateral renal aplasia. Clin Genet 1975, 7 (5), 368-381.
4. Conrad, B.; Kriebel, J.; Hetzel, W. D., Hereditary bimanual synkinesis combined with hypogonadotropic hypogonadism and anosmia in four brothers. J Neurol 1978, 218 (4), 263-274.
5. Hermanussen, M.; Sippell, W. G., Heterogeneity of Kallmann's syndrome. Clin Genet 1985, 28 (2), 106-111.
6. Sparkes, R. S.; Simpson, R. W.; CA, P., Familial hypogonado tropic hypogonadism with anosmia. Arch Intern Med 1968, 121 (6), 534-538.
7. White, B. J.; Rogol, A. D.; Brown, K. S.; Lieblich, J. M.; Rosen, S. W., The syndrome of anosmia with hypogonadotropic hypogona dism: a genetic study of 18 new families and a review. Am J Med Genet 1983, 15 (3), 417-435.
8. Chaussain, J. L.; Toublanc, J. E.; Feingold, J.; Naud, C.; Vassal, J.; Job, J. C., Mode of inheritance in familial cases of primary gonado tropic deficiency. Horm Res 1988, 29 (5-6), 202-206.
9. Schwanzel-Fukuda, M.; Bick, D.; Pfaff, D. W., Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 1989, 6 (4), 311-326.
10. Legouis, R.; Lievre, C. A.; Leibovici, M.; Lapointe, F.; Petit, C., Expression of the KAL gene in multiple neuronal sites during chicken development. Proc Natl Acad Sci U S A 1993, 90 (6), 2461-2465.
11. Lutz, B.; Rugarli, E. I.; Eichele, G.; Ballabio, A., X-linked Kallmann syndrome. A neuronal targeting defect in the olfactory system? FEBS Lett 1993, 325 (1-2), 128-134.
12. Quinton, R.; Duke, V. M.; de Zoysa, P. A.; Platts, A. D.; Valentine, A.; Kendall, B.; Pickman, S.; Kirk, J. M.; Besser, G. M.; Jacobs, H. S.; Bouloux, P. M., The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab 1996, 81 (8), 3010-3017.
13. MacColl, G.; Quinton, R.; Bouloux, P. M., GnRH neuronal development: insights into hypogonadotrophic hypogonadism. Trends Endocrinol Metab 2002, 13 (3), 112-118.
14. Truwit, C. L.; Barkovich, A. J.; Grumbach, M. M.; Martini, J. J., MR imaging of Kallmann syndrome, a genetic disorder of neuronal migration affecting the olfactory and genital systems. AJNR Am J Neuroradiol 1993, 14 (4), 827-838.
15. Cariboni, A.; Maggi, R., Kallmann's syndrome, a neuronal migra tion defect. Cellular and Molecular Life Sciences 2006, 63 (21), 2512-2526.
16. Hu, Y. L.; Bouloux, P. M., X-linked GnRH deficiency: Role of KAL-1 mutations in GnRH deficiency. Molecular and Cellular Endocrinology 2011, 346 (1-2), 13-20.
17. Legouis, R.; Hardelin, J. P.; Levilliers, J.; Claverie, J. M.; Compain, S.; Wunderle, V.; Millasseau, P.; Le Paslier, D.; Cohen, D.; Caterina, D.; et al., The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991, 67 (2), 423-435.
18. Franco, B.; Guioli, S.; Pragliola, A.; Incerti, B.; Bardoni, B.; Tonlorenzi, R.; Carrozzo, R.; Maestrini, E.; Pieretti, M.; Taillonmiller, P.; Brown, C. J.; Willard, H. F.; Lawrence, C.; Persico, M. G.; Camerino, G.; Ballabio, A., A gene deleted in Kallmanns Syndrome shares homology with neural cell-adhesion and axonal path-finding molecules. Nature 1991, 353 (6344), 529-536.
19. Hennighausen, L. G.; Sippel, A. E., Mouse whey acidic protein is a novel member of the family of 'four-disulfide core' proteins. Nucleic Acids Res 1982, 10 (8), 2677-2684.
20. Dandekar, A. M.; Robinson, E. A.; Appella, E.; Qasba, P. K., Complete sequence analysis of cDNA clones encoding rat whey phosphoprotein: homology to a protease inhibitor. Proc Natl Acad Sci U S A 1982, 79 (13), 3987-3991.
21. Lander, A. D., Understanding the molecules of neural cell contacts: emerging patterns of structure and function. Trends Neurosci 1989, 12 (5), 189-195.
22. Edelman, G. M.; Crossin, K. L., Cell adhesion molecules: implications for a molecular histology. Annu Rev Biochem 1991, 60, 155-190.
23. Rugarli, E. I.; Di Schiavi, E.; Hilliard, M. A.; Arbucci, S.; Ghezzi, C.; Facciolli, A.; Coppola, G.; Ballabio, A.; Bazzicalupo, P., The Kallmann syndrome gene homolog in C-elegans is involved in epidermal morphogenesis and neurite branching. Development 2002, 129 (5), 1283-1294.
24. Bulow, H. E.; Berry, K. L.; Topper, L. H.; Peles, E.; Hobert, O., Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proceedings of the National Academy of Sciences of the United States of America 2002, 99 (9), 6346-6351.
25. Andrenacci, D.; Le Bras, S.; Grimaldi, M. R.; Rugarli, E.; Graziani, F., Embryonic expression pattern of the Drosophila Kallmann syndrome gene kal-1. Gene Expression Patterns 2004, 5 (1), 67-73.
26. Dode, C.; Hardelin, J. P., Kallmann syndrome. Eur J Hum Genet 2009, 17 (2), 139-146.
27. Hardelin, J. P.; Dode, C., The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev 2008, 2 (4-5), 181-193.
28. Dode, C.; Levilliers, J.; Dupont, J. M.; De Paepe, A.; Le Du, N.; Soussi-Yanicostas, N.; Coimbra, R. S.; Delmaghani, S.; Compain-Nouaille, S.; Baverel, F.; Pecheux, C.; Le Tessier, D.; Cruaud, C.; Delpech, M.; Speleman, F.; Vermeulen, S.; Amalfitano, A.; Bachelot, Y.; Bouchard, P.; Cabrol, S.; Carel, J. C.; Delemarre-van de Waal, H.; Goulet-Salmon, B.; Kottler, M. L.; Richard, O.; Sanchez-Franco, F.; Saura, R.; Young, J.; Petit, C.; Hardelin, J. P., Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nature Genetics 2003, 33 (4), 463-465.
29. Dode, C.; Hardelin, J. P., Kallmann syndrome: fibroblast growth factor signaling insufficiency? Journal of Molecular Medicine-Jmm 2004, 82 (11), 725-734.
30. Falardeau, J.; Chung, W. C. J.; Beenken, A.; Raivio, T.; Plummer, L.; Sidis, Y.; Jacobson-Dickman, E. E.; Eliseenkova, A. V.; Ma, J.; Dvfyer, A.; Quinton, R.; Na, S.; Hall, J. E.; Huot, C.; Alois, N.; Pearce, S. H. S.; Cole, L. W.; Hughes, V.; Mohammadi, M.; Tsai, P.; Pitteloud, N., Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. Journal of Clinical Investigation 2008, 118 (8), 2822-2831.
31. Dode, C.; Teixeira, L.; Levilliers, J.; Fouveaut, C.; Bouchard, P.; Kottler, M. L.; Lespinasse, J.; Lienhardt-Roussie, A.; Mathieu, M.; Moerman, A.; Morgan, G.; Murat, A.; Toublanc, J. E.; Wolczynski, S.; Delpech, M.; Petit, C.; Young, J.; Hardelin, J. P., Kallmann syndrome: Mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. Plos Genetics 2006, 2 (10), 1648-1652.
32. Kim, H. G.; Kurth, I.; Lan, F.; Meliciani, I.; Wenzel, W.; Eom, S. H.; Kang, G. B.; Rosenberger, G.; Tekin, M.; Ozata, M.; Bick, D. P.; Sherins, R. J.; Walker, S. L.; Shi, Y.; Gusella, J. F.; Layman, L. C., Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 2008, 83 (4), 511-519.
33. Tornberg, J.; Sykiotis, G. P.; Keefe, K.; Plummer, L.; Hoang, X.; Hall, J. E.; Quinton, R.; Seminara, S. B.; Hughes, V.; Van Vliet, G.; Van Uum, S.; Crowley, W. F.; Habuchi, H.; Kimata, K.; Pitteloud, N.; Bulow, H. E., Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proceedings of the National Academy of Sciences of the United States of America 2011, 108 (28), 11524-11529.
34. Zhang, X. Q.; Ibrahimi, O. A.; Olsen, S. K.; Umemori, H.; Mohammadi, M.; Ornitz, D. M., Receptor specificity of the fibroblast growth factor family-The complete mammalian FGF family. Journal of Biological Chemistry 2006, 281 (23), 15694-15700.
35. Cole, L. W.; Sidis, Y.; Zhang, C.; Quinton, R.; Plummer, L.; Pignatelli, D.; Hughes, V. A.; Dwyer, A. A.; Raivio, T.; Hayes, F. J.; Seminara, S. B.; Huot, C.; Alos, N.; Speiser, P.; Takeshita, A.; Van Vliet, G.; Pearce, S.; Crowley, W. F.; Zhou, Q. Y.; Pitteloud, N., Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: Molecular genetics and clinical spectrum. Journal of Clinical Endocrinology & Metabolism 2008, 93 (9), 3551-3559.
36. Kim, H. G.; Layman, L. C., The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonado tropic hypogonadism and Kallmann syndrome. Mol Cell Endocri nol 2011, 346 (1-2), 74-83.
37. Miraoui, H.; Dwyer, A.; Pitteloud, N., Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction. Mol Cell Endocrinol 2011, 346 (1-2), 37-43.
38. Mitchell, A. L.; Dwyer, A.; Pitteloud, N.; Quinton, R., Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab 2011, 22 (7), 249-258.
39. SoussiYanicostas, N.; Hardelin, J. P.; ArroyoJimenez, M. D.; Ardouin, O.; Legouis, R.; Levilliers, J.; Traincard, F.; Betton, J. M.; Cabanie, L.; Petit, C., Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. Journal of Cell Science 1996, 109, 1749-1757.
40. Soussi-Yanicostas, N.; Faivre-Sarrailh, C.; Hardelin, J. P.; Levilliers, J.; Rougon, G.; Petit, C., Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. Journal of Cell Science 1998, 111, 2953-2965.
41. Hu, Y. L.; Gonzalez-Martinez, D.; Kim, S. H.; Bouloux, P. M. G., Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator. Biochemical Journal 2004, 384, 495-505.
42. Hudson, M. L.; Kinnunen, T.; Cinar, H. N.; Chisholm, A. D., Celegans Kallmann syndrome protein KAL-1 interacts with syndecan and glypican to regulate neuronal cell migrations. Developmental Biology 2006, 294 (2), 352-365.
43. Axang, C.; Rauthan, M.; Hall, D. H.; Pilon, M., Developmental genetics of the C. elegans pharyngeal neurons NSML and NSMR. BMC Dev Biol 2008, 8, 38.
44. Andrenacci, D.; Grimaldi, M. R.; Panetta, V.; Riano, E.; Rugarli, E. I.; Graziani, F., Functional dissection of the Drosophila Kallmann's syndrome protein DmKal-1. Bmc Genetics 2006, 7.
45. Bulow, H. E.; Hobert, O., Differential sulfations and epimerization define heparan sulfate specificity in nervous system development. Neuron 2004, 41 (5), 723-736.
46. Bhattacharya, R.; Townley, R. A.; Berry, K. L.; Bulow, H. E., The PAPS transporter PST-1 is required for heparan sulfation and is essential for viability and neural development in C. elegans. J Cell Sci 2009, 122 (Pt 24), 4492-4504.
47. Bulow, H. E.; Hobert, O., The molecular diversity of glycosamino glycans shapes animal development. Annu Rev Cell Dev Biol 2006, 22, 375-407.
48. Rugarli, E. I.; Lutz, B.; Kuratani, S. C.; Wawersik, S.; Borsani, G.; Ballabio, A.; Eichele, G., Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nat Genet 1993, 4 (1), 19-26.
49. Hebert, J. M.; Lin, M.; Partanen, J.; Rossant, J.; McConnell, S. K., FGF signaling through FGFR1 is required for olfactory bulb morphogenesis. Development 2003, 130 (6), 1101-1111.
50. Cadman, S. M.; Kim, S. H.; Hu, Y. L.; Gonzalez-Martinez, D.; Bouloux, P. M., Molecular pathogenesis of Kallmann's syndrome. Hormone Research 2007, 67 (5), 231-242.
51. Gonzalez-Martinez, D.; Kim, S. H.; Hu, Y. L.; Guimond, S.; Schofield, J.; Winyard, P.; Vannelli, G. B.; Turnbull, J.; Bouloux, P. M., Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism. Journal of Neuroscience 2004, 24 (46), 10384-10392.
52. Hu, Y. L.; Bouloux, P. M., Novel insights in FGFR1 regulation: lessons from Kallmann syndrome. Trends in Endocrinology and Metabolism 2010, 21 (6), 385-393.
53. Hu, Y.; Guimond, S. E.; Travers, P.; Cadman, S.; Hohenester, E.; Turnbull, J. E.; Kim, S. H.; Bouloux, P. M., Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1. J Biol Chem 2009, 284 (43), 29905-29920.
54. Bulow, H. E.; Boulin, T.; Hobert, O., Differential functions of the C. elegans FGF receptor in axon outgrowth and maintenance of axon position. Neuron 2004, 42 (3), 367-374.
55. Oliveira, L. M. B.; Seminara, S. B.; Beranova, M.; Hayes, F. J.; Valkenburgh, S. B.; Schipani, E.; Costa, E. M. F.; Latronico, A. C.; Crowley, W. F.; Vallejo, M., The importance of autosomal genes in Kallmann syndrome: Genotype-phenotype correlations and neu roendocrine characteristics. Journal of Clinical Endocrinology & Metabolism 2001, 86 (4), 1532-1538.
56. Sato, N.; Katsumata, N.; Kagami, M.; Hasegawa, T.; Hori, N.; Kawakita, S.; Minowada, S.; Shimotsuka, A.; Shishiba, Y.; Yokozawa, M.; Yasuda, T.; Nagasaki, K.; Hasegawa, D.; Hasegawa, Y.; Tachibana, K.; Naiki, Y.; Horikawa, R.; Tanaka, T.; Ogata, T., Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. Journal of Clinical Endocrinology & Metabolism 2004, 89 (3), 1079-1088.
57. Murcia-Belmonte, V.; Esteban, P. F.; Garcia-Gonzalez, D.; De Castro, F., Biochemical dissection of Anosmin-1 interaction with FGFR1 and components of the extracellular matrix. J Neurochem 2010, 115 (5), 1256-1265.
58. Giacobini, P.; Messina, A.; Morello, F.; Ferraris, N.; Corso, S.; Penachioni, J.; Giordano, S.; Tamagnone, L.; Fasolo, A., Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex. J Cell Biol 2008, 183 (3), 555-566.
59. Cariboni, A.; Davidson, K.; Rakic, S.; Maggi, R.; Parnavelas, J. G.; Ruhrberg, C., Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: implications for the aetiology of hypogonadotropic hypogonadism. Hum Mol Genet 2010, 20 (2), 336-344.
60. Messina, A.; Ferraris, N.; Wray, S.; Cagnoni, G.; Donohue, D. E.; Casoni, F.; Kramer, P. R.; Derijck, A. A.; Adolfs, Y.; Fasolo, A.; Pasterkamp, R. J.; Giacobini, P., Dysregulation of Semapho rin7A/beta1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Hum Mol Genet 2011, 20 (24), 4759-4774.
61. Hanchate, N. K.; Giacobini, P.; Lhuillier, P.; Parkash, J.; Espy, C.; Fouveaut, C.; Leroy, C.; Baron, S.; Campagne, C.; Vanacker, C.; Collier, F.; Cruaud, C.; Meyer, V.; Garcia-Pinero, A.; Dewailly, D.; Cortet-Rudelli, C.; Gersak, K.; Metz, C.; Chabrier, G.; Pugeat, M.; Young, J.; Hardelin, J. P.; Prevot, V.; Dode, C., SEMA3A, a Gene Involved in Axonal Pathfinding, Is Mutated in Patients with Kallmann Syndrome. PLoS Genet 2012, 8 (8), e1002896.
62. Young, J.; Metay, C.; Bouligand, J.; Tou, B.; Francou, B.; Maione, L.; Tosca, L.; Sarfati, J.; Brioude, F.; Esteva, B.; Briand-Suleau, A.; Brisset, S.; Goossens, M.; Tachdjian, G.; Guiochon-Mantel, A., SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development. Hum Reprod 2012, 27 (5), 1460-1465.
63. De Wit, J.; De Winter, F.; Klooster, J.; Verhaagen, J., Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrix. Mol Cell Neurosci 2005, 29 (1), 40-55.
64. Hipkin, L. J.; Casson, I. F.; Davis, J. C., Identical twins discordant for Kallmann's syndrome. J Med Genet 1990, 27 (3), 198-199.
65. Hu, Y. L.; Tanriverdi, F.; MacColl, G. S.; Bouloux, P. M. G., Kallmann's syndrome: molecular pathogenesis. International Journal of Biochemistry & Cell Biology 2003, 35 (8), 1157-1162.
66. Altun-Gultekin, Z.; Andachi, Y.; Tsalik, E. L.; Pilgrim, D.; Kohara, Y.; Hobert, O., A regulatory cascade of three homeobox genes, ceh-10, ttx-3 and ceh-23, controls cell fate specification of a defined interneuron class in C. elegans. Development 2001, 128 (11), 1951-1969.
67. Tsalik, E. L.; Niacaris, T.; Wenick, A. S.; Pau, K.; Avery, L.; Hobert, O., LIM homeobox gene-dependent expression of biogenic amine receptors in restricted regions of the C. elegans nervous system. Dev Biol 2003, 263 (1), 81-102.
68. Magdaleno, S.; Jensen, P.; Brumwell, C. L.; Seal, A.; Lehman, K.; Asbury, A.; Cheung, T.; Cornelius, T.; Batten, D. M.; Eden, C.; Norland, S. M.; Rice, D. S.; Dosooye, N.; Shakya, S.; Mehta, P.; Curran, T., BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system. PLoS Biol 2006, 4 (4), e86.
69. Visel, A.; Carson, J.; Oldekamp, J.; Warnecke, M.; Jakubcakova, V.; Zhou, X.; Shaw, C. A.; Alvarez-Bolado, G.; Eichele, G., Regu latory pathway analysis by high-throughput in situ hybridization. PLoS Genet 2007, 3 (10), 1867-1883.